Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins

Angiology

Volumn 57, Issue 4, 2006, Pages 418-423

  Ferrara, Filippo ^a,b   Meli, Francesco ^a   Amato, Corrado ^a   Cospite, Valentina ^a   Raimondi, Francesco ^a   Novo, Giuseppe ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ABDOMINAL SURGERY; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CALF VENOUS THROMBOSIS; COLOR ULTRASOUND FLOWMETRY; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; FEMALE; FEMORAL VEIN; HEPARINIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POPLITEAL VEIN; POSTOPERATIVE COMPLICATION; TREATMENT DURATION; TREATMENT OUTCOME; UROLOGIC SURGERY; VEIN THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; NADROPARIN; POSTOPERATIVE COMPLICATIONS; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS; WARFARIN;

EID: 33748987624     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706290745     Document Type: Article

References (32)

1. Giachino A: Relationship between deep-vein thrombosis in the calf and fatal pulmonary embolism. Can J Surg 31:129-130, 1988.
2. Ohgi S, Tachibana M, Ikebuchi M, et al: Pulmonary embolism in patients with isolated soleal vein thrombosis. Angiology 49:759-764, 1998.
3. Gottlieb RH, Widjaja J, Mehrs S, et al: Clinically important pulmonary emboli: Does calf vein US alter outcomes? Radiology 211:25-29, 1999.
4. Kazmers A, Groehn H, Meeker C: Acute calf vein thrombosis: Outcomes and implications. Am Surg 65:1124-1127, 1999.
5. Guias B, Simoni G, Oger E, et al: Calf muscle venous thrombosis and pulmonary embolism. J Mal Vasc 24:132-134, 1999.
6. Meissner MH, Caps MT, Bergelin RO, et al: Early outcome after isolated calf vein thrombosis. J Vasc Surg 26:749-756, 1997.
7. Krunes U, Teubner K, Knipp H, et al: Thrombosis of the muscular calf veins-references to a syndrome, which receives little attention. Vasa 27:172-175, 1998.
8. Hollerweger A, Macheiner P, Redenbacher T, et al: Sonograpohic diagnosis of thrombosis of the calf muscle veins and the risk of pulmonary embolism. Ultraschall Med 21:66-72, 2000.
9. Baumgartner I, Braunschweig M, Triller J, et al: Power-based colour coded duplex sonography for evaluation of calf veins. Int Angiol 17:43-48, 1998.
10. Forbes K, Stevenson AJ: The use of power Doppler ultrasound in the diagnosis of isolated deep venous thrombosis of the calf. Clin Radiol 53:752-754, 1998.
11. Gottlieb RH, Widjaja J, Tian L, et al: Calf sonography for detecting deep venous thrombosis in symptomatic patients, experience and review of the literature. J Clin Ultrasound 27:415-420, 1999.
12. Meissner MH: Duplex follow-up of patients with DVT. does it have clinical significance? Semin Vasc Surg 14:215-221, 2001.
13. Wells PS, Lensing AWA, Davidson BL, et al: Accuracy of ultrasound for the diagnosis of deep vein thrombosis in asymptomatic patients after orthopedic surgery. Ann Intern Med 122:47-53, 1995.
14. Bosson JL, Riachi M, Pichot O, et al: Diameters of acute proximal and distal deep venous thrombosis of the lower limbs. Int Angiol 17:260-267, 1998.
15. Barradel LB, Buckley MM: Nadroparin calcium: A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Drugs 44:858-888, 1992.
16. Diquelou A, Dupouy D, Cariou R, et al: A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis. Thromb Haemost 74:1286-1292, 1995.
17. Hirsh J: Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Haemostasis 26:189-198, 1996.
18. Davis R, Faulds D: Nadroparin calcium. A review of its pharmacological and clinical use in the prevention and treatment of thromboembolic disorders. Drugs Aging 10:299-322, 1997.
19. Stricker H, Marchetti O, Haeberli A, et al: Hemostatic activation under anticoagulant treatment: A comparison of unfractionated heparin vs Nadroparin in the treatment of proximal deep vein thrombosis. Thromb Haemost 82:1227-1231, 1999.
20. Breddin HK: Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery. Semin Thromb Hemost 25:83-89, 1999.
21. Egger B, Schmid SW, Naef M, et al: Efficacy and safety of weight-adapted nadroparin calcium vs heparin sodium in prevention of clinically evident thromboembolic complications in 1,990 general surgical patients. Dig Surg 17:602-609, 2000.
22. PIOPED Investigators: Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis. JAMA 263:2753-2759, 1990.
23. van Beek EJR, Kuyer PMN, Schenk BE, et al: A normal perfusion lung scan in patients with clinical suspected pulmonary embolism. Frequency and clinical validity. Chest 108:170-173, 1995.
24. Miniati M, Pistolesi M, Marini C, et al (The PISA-PED Investigators): Value of perfusion lung scan in the diagnosis of pulmonary embolism. Results of the Prospective Investigative Study of Acute Pulmonary Embolism. Diagnosis. Am J Crit Care Med 154:1387-1393, 1996.
25. de Grooth MR, Turkstraa F, van Marwijk Kooy M, et al: Value of chest x-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism Thromb Hemost 83:412-415, 2000.
26. Favretto G: A proposito di scintigrafia polmonare nella diagnosi di embolia polmonare. Ital Heart J 3(suppl):95-99, 2002.
27. Pinede L, Ninet J, Duhaut P, et al: Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103:2453-2460, 2001.
28. Pinede L, Cucherat M, Duhaut P, et al: Optimal duration of anticoagulant therapy after an episode of venous thromboembolism. Blood Coagul Fibrinolysis 11:701-707, 2000.
29. Astermark J, Bjorgell O, Linden E, et al: Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med 244:79-82, 1998.
30. Pellegrini VD Jr, Clement D, Lush-Ehmann C, et al: The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop 333:27-40, 1966.
31. Ferrara F, Meli F, Raimondi F, et al: Incidence of proximal extension of thrombotic lesions and pulmonary embolism in untreated patients with calf vein thrombosis. Haematologica 88:1, 2003.
32. Pinede L: Duration of oral anticoagulant therapy in deep venous thrombosis of the lower limbs. Ann Cardiol Angeiol 51:158-163, 2002.